Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
Penumbra (PEN) reported $301.04 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 11.1%. EPS of $0.85 for the same period compares to $0.67 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $298.09 million, representing a surprise of +0.99%. The company delivered an EPS surprise of +23.19%, with the consensus EPS estimate being $0.69.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Penumbra performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Geographic Revenue- United States: $226.33 million versus the three-analyst average estimate of $226.95 million. The reported number represents a year-over-year change of +16.2%. Geographic Revenue- International: $74.71 million compared to the $73.17 million average estimate based on three analysts. The reported number represents a change of -1.9% year over year. Revenue- Embolization and Access: $96.90 million versus the two-analyst average estimate of $99.68 million. Revenue- Thrombectomy: $204.14 million compared to the $201.21 million average estimate based on two analysts. View all Key Company Metrics for Penumbra here>>>Shares of Penumbra have returned +9.4% over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Penumbra, Inc. (PEN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Penumbra
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Penumbra
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Penumbra Inc
Analysen zu Penumbra Inc
Datum | Rating | Analyst | |
---|---|---|---|
15.12.2017 | Penumbra Market Perform | BMO Capital Markets | |
24.10.2016 | Penumbra Outperform | BMO Capital Markets | |
30.11.2015 | Penumbra Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
15.12.2017 | Penumbra Market Perform | BMO Capital Markets | |
24.10.2016 | Penumbra Outperform | BMO Capital Markets | |
30.11.2015 | Penumbra Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Penumbra Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen